Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut H Popper

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|May 3, 2005
Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridizationIris Halbwedl, Reinhard Ullmann, Marie-Luise Kremser, et al.
Molecular Oncology|August 11, 2020
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancerElisabeth Smolle, Petra Leko, Elvira Stacher-Priehse, et al.
Virchows Archiv : an International Journal of Pathology|March 10, 2018
Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lungLuka Brcic, Stefanie Stanzer, Dagmar Krenbek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Vincent Haddad, Katharina Schmid, et al.
Human Pathology|May 13, 2004
Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: A genetic analysisElvira Stacher, Reinhard Ullmann, Iris Halbwedl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Robert Pirker, Ariane Dunant, et al.
BMC Cancer|January 28, 2014
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cellsKatharina Leithner, Christoph Wohlkoenig, Elvira Stacher, et al.
The New England Journal of Medicine|September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyKen A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete ResectionMing-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
Cancer Research|October 28, 2010
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinomaJohannes Voortman, Akiteru Goto, Jean Mendiboure, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|May 3, 2005
Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridizationIris Halbwedl, Reinhard Ullmann, Marie-Luise Kremser, et al.
Molecular Oncology|August 11, 2020
Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancerElisabeth Smolle, Petra Leko, Elvira Stacher-Priehse, et al.
Virchows Archiv : an International Journal of Pathology|March 10, 2018
Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lungLuka Brcic, Stefanie Stanzer, Dagmar Krenbek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Vincent Haddad, Katharina Schmid, et al.
Human Pathology|May 13, 2004
Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: A genetic analysisElvira Stacher, Reinhard Ullmann, Iris Halbwedl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Robert Pirker, Ariane Dunant, et al.
BMC Cancer|January 28, 2014
Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cellsKatharina Leithner, Christoph Wohlkoenig, Elvira Stacher, et al.
The New England Journal of Medicine|September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyKen A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete ResectionMing-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
Cancer Research|October 28, 2010
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinomaJohannes Voortman, Akiteru Goto, Jean Mendiboure, et al.
Pageof 7